Lexicon Pharmaceuticals Inc (STU:LX31)
€ 4.096 0 (0%) Market Cap: 275.49 Mil Enterprise Value: 126.67 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 52/100

Lexicon Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 07:50PM GMT
Release Date Price: €7.05 (+125.38%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Great. Good afternoon, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan. And we're continuing the 2021 Health Care Conference today with Lexicon.

Quick housekeeping note before we get started. Unlike in years past, this year is a little different. So we can't just go across the hall for a breakout session. You can use that blue Ask a Question button on your screen. That'll send me questions over the portal. I can ask them to management during Q&A after the presentation.

So with that out of the way, let me turn it over to Lexicon's CEO, Lonnel Coats.

Lonnel Coats
Lexicon Pharmaceuticals, Inc. - President, CEO & Director

Jessica, thank you, and good afternoon, everyone, for joining us on this call today.

As always, when I start this presentation, I start off by thanking all the extraordinary men and women here at Lexicon that work tirelessly every day to advance our science into the hands of patients.

Today, I'll be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot